abirateron eg 250 mg filmtablette
eurogenerics afgekort "e.g." - abiraterone acetat - filmtablette - 250 mg - abiraterone acetat 250 mg - abiraterone
abirateron eg 500 mg filmtablette
eurogenerics afgekort "e.g." - abiraterone acetat - filmtablette - 500 mg - abiraterone acetat 500 mg - abiraterone
abirateron fresenius kabi 500 mg filmtablette
fresenius kabi - abiraterone acetat - filmtablette - 500 mg - abiraterone acetat 500 mg - abiraterone
abirateron fresenius kabi 250 mg tablette
fresenius kabi - abiraterone acetat - tablette - 250 mg - abiraterone acetat 250 mg - abiraterone
bixodalan 250 mg filmtablette
sandoz - abiraterone acetat - filmtablette - 250 mg - abiraterone acetat 250 mg - abiraterone
bixodalan 500 mg filmtablette
sandoz - abiraterone acetat - filmtablette - 500 mg - abiraterone acetat 500 mg - abiraterone
bixodalan 1000 mg filmtablette
sandoz - abiraterone acetat - filmtablette - 1000 mg - abiraterone acetat 1000 mg - abiraterone
abiraterone mylan
mylan ireland limited - abirateronacetat - prostata-neoplasmen - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
abiraterone krka
krka, d.d., novo mesto - abirateronacetat - prostata-neoplasmen - endokrine therapie - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.
abiraterone accord
accord healthcare s.l.u. - abirateronacetat - prostata-neoplasmen - endokrine therapie - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.